HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypermagnesemia and progression of renal failure associated with renacidin therapy.

Abstract
Renacidin is a urinary stone dissolving agent composed primarily of gluconic and citric acids and their magnesium salts, buffered to a pH of 4. We describe its use in a child with oxalosis, disabling renal colic and deteriorating renal function in whom its use was associated with hypermagnesemia and rapid progression of the renal failure. Possible mechanisms for the deterioration in renal function are discussed.
AuthorsC Wilson, A F Azmy, T J Beattie, A V Murphy
JournalClinical nephrology (Clin Nephrol) Vol. 25 Issue 5 Pg. 266-7 (May 1986) ISSN: 0301-0430 [Print] Germany
PMID3720036 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Citrates
  • Pharmaceutic Aids
  • hemiacidrin
  • Magnesium
Topics
  • Child
  • Citrates (adverse effects, therapeutic use)
  • Colic (drug therapy)
  • Female
  • Humans
  • Kidney Diseases (drug therapy)
  • Kidney Failure, Chronic (chemically induced)
  • Magnesium (blood)
  • Nephrocalcinosis (drug therapy)
  • Pharmaceutic Aids (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: